|
US8937153B2
(en)
*
|
2007-07-31 |
2015-01-20 |
Affibody Ab |
Compositions, methods and uses
|
|
WO2010141329A1
(en)
*
|
2009-06-01 |
2010-12-09 |
Medimmune, Llc |
Molecules with extended half-lives and uses thereof
|
|
CN102811782A
(zh)
*
|
2010-03-08 |
2012-12-05 |
通用电气健康护理生物科学股份公司 |
免疫球蛋白G Fc区结合多肽
|
|
PH12012502018A1
(en)
*
|
2010-04-30 |
2018-03-21 |
Sanwa Kagaku Kenkyusho Co |
Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability
|
|
NZ604805A
(en)
*
|
2010-07-09 |
2014-09-26 |
Affibody Ab |
Polypeptides
|
|
MX339622B
(es)
*
|
2010-08-02 |
2016-06-02 |
Macrogenics Inc |
Diacuerpos covalentes y sus usos.
|
|
EA201390450A1
(ru)
|
2010-09-28 |
2013-07-30 |
Амилин Фармасьютикалс, Ллк. |
Полипептиды с увеличенной продолжительностью действия
|
|
JP2014502252A
(ja)
*
|
2010-09-28 |
2014-01-30 |
アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー |
作用持続時間が増した改変ポリペプチド
|
|
CN113278077A
(zh)
|
2010-11-26 |
2021-08-20 |
分子组合公司 |
设计的与血清白蛋白结合的重复蛋白
|
|
EA201391753A1
(ru)
*
|
2011-05-21 |
2014-08-29 |
Макродженикс, Инк. |
Домены, связывающиеся с деиммунизованной сывороткой, и их применение для увеличения времени полужизни в сыворотке
|
|
JP6006309B2
(ja)
*
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
ES2732475T3
(es)
|
2011-07-08 |
2019-11-22 |
Aegerion Pharmaceuticals Inc |
Polipéptidos modificados por ingeniería genética que tienen una duración potenciada de la acción y una inmunogenicidad reducida
|
|
RS58503B1
(sr)
|
2012-02-20 |
2019-04-30 |
Swedish Orphan Biovitrum Ab Publ |
Polipeptidi koji se vezuju za humani komplement c5
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
EP2844269A4
(en)
*
|
2012-03-28 |
2016-01-06 |
Amylin Pharmaceuticals Llc |
TRANSMUCOSAL ADMINISTRATION OF MANIPULATED POLYPEPTIDES
|
|
US20160009767A9
(en)
|
2012-03-28 |
2016-01-14 |
Affibody Ab |
Oral administration
|
|
BR112014029409B1
(pt)
|
2012-05-25 |
2022-11-29 |
Janssen Biotech, Inc |
Domínio de ligação a albumina isolado não natural, método para produção do mesmo, polinucleotídeo isolado, vetor isolado, célula hospedeira isolada, proteína de fusão e composição farmacêutica
|
|
US10155792B2
(en)
|
2012-09-25 |
2018-12-18 |
Affibody Ab |
Albumin binding polypeptide
|
|
KR102191655B1
(ko)
|
2012-10-05 |
2020-12-16 |
애피바디 에이비 |
Her3 결합 폴리펩티드
|
|
EP2912051B1
(en)
*
|
2012-10-25 |
2018-04-18 |
Affibody AB |
Method for the separation of proteins containing an albumin-binding domain
|
|
AU2013336646B2
(en)
|
2012-10-25 |
2016-07-14 |
Affibody Ab |
ABD binding polypeptide
|
|
WO2014076179A1
(en)
|
2012-11-14 |
2014-05-22 |
Affibody Ab |
New polypeptide
|
|
US9255262B2
(en)
*
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
HK1218534A1
(zh)
*
|
2013-03-14 |
2017-02-24 |
多伦多大学管理委员会 |
支架化肽文库以及其制备和筛选方法
|
|
SG11201505856TA
(en)
|
2013-03-14 |
2015-08-28 |
Daiichi Sankyo Co Ltd |
Novel binding proteins for pcsk9
|
|
EP2970406B1
(en)
|
2013-03-15 |
2017-12-13 |
Affibody AB |
New polypeptides
|
|
CN105209054A
(zh)
|
2013-04-18 |
2015-12-30 |
阿尔莫生物科技股份有限公司 |
使用白细胞介素-10治疗疾病和病症的方法
|
|
JP2016528879A
(ja)
|
2013-06-17 |
2016-09-23 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
タンパク質の同一性および安定性を評価する方法
|
|
JP6767865B2
(ja)
|
2013-08-28 |
2020-10-14 |
スウェディッシュ・オーファン・バイオヴィトラム・アーベー（ペーウーベーエル） |
ヒト補体ｃ５に結合する安定なポリペプチド
|
|
KR102497083B1
(ko)
|
2013-08-28 |
2023-02-07 |
애피바디 에이비 |
돌연변이된 스캐폴드를 갖는 결합 폴리펩티드
|
|
HK1226308A1
(zh)
|
2013-08-30 |
2017-09-29 |
Armo Biosciences, Inc. |
使用白细胞介素-10治疗疾病和病症的方法
|
|
US11413332B2
(en)
|
2013-11-11 |
2022-08-16 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
EP3083675B1
(en)
|
2013-12-20 |
2018-03-07 |
Affibody AB |
Engineered albumin binding polypeptide
|
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
TN2016000578A1
(en)
|
2014-07-30 |
2018-04-04 |
Ngm Biopharmaceuticals Inc |
Compositions and methods of use for treating metabolic disorders
|
|
US10323066B2
(en)
|
2014-09-17 |
2019-06-18 |
Affibody Ab |
Neonatal Fc receptor binding dimer and methods of use
|
|
KR20170068553A
(ko)
|
2014-10-14 |
2017-06-19 |
아르모 바이오사이언시스 인코포레이티드 |
인터류킨-15 조성물 및 이의 용도
|
|
JP6675394B2
(ja)
|
2014-10-22 |
2020-04-01 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
疾患及び障害の治療のためにインターロイキン−１０を使用する方法
|
|
EP3212226B1
(en)
|
2014-10-31 |
2020-03-18 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
PT3245224T
(pt)
|
2015-01-12 |
2020-10-08 |
Affibody Ab |
Polipéptidos de ligação a il-17a
|
|
US10618970B2
(en)
|
2015-02-03 |
2020-04-14 |
Armo Biosciences, Inc. |
Method of treating cancer with IL-10 and antibodies that induce ADCC
|
|
EP3291828A4
(en)
|
2015-05-06 |
2018-10-03 |
Alborz Mahdavi |
Glucose responsive insulins
|
|
US20160361415A1
(en)
|
2015-05-28 |
2016-12-15 |
Armo Biosciences, Inc. |
Methods of Using Interleukin-10 for Treating Diseases and Disorders
|
|
WO2017024182A1
(en)
|
2015-08-04 |
2017-02-09 |
Duke University |
Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same
|
|
JP7053453B2
(ja)
|
2015-08-25 |
2022-04-12 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
疾患及び障害を治療するためのインターロイキン１０の使用方法
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
CN107022031A
(zh)
*
|
2016-01-29 |
2017-08-08 |
中国人民解放军军事医学科学院微生物流行病研究所 |
融合蛋白HSA1-Vβ1及其应用
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
EP3515928B1
(en)
|
2016-09-23 |
2026-01-28 |
Duke University |
Unstructured non-repetitive polypeptides having lcst behavior
|
|
CN107952080A
(zh)
*
|
2016-10-14 |
2018-04-24 |
中国科学院过程工程研究所 |
一种肿瘤靶向多肽-药物偶联衍生物、其制备方法及应用
|
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
EP3658168A4
(en)
|
2017-06-30 |
2021-07-14 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULUS SENSITIVE BIOPOLYMER NETWORKS
|
|
US11077199B2
(en)
|
2017-08-09 |
2021-08-03 |
Massachusetts Institute Of Technology |
Albumin binding peptide conjugates and methods thereof
|
|
US20200239575A1
(en)
*
|
2017-10-06 |
2020-07-30 |
University Of Utah Research Foundation |
A fusion protein for targeted therapy of autoimmune disease
|
|
EP3691693A4
(en)
*
|
2017-10-06 |
2021-08-25 |
University Of Utah Research Foundation |
FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE
|
|
WO2019147954A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
WO2019175176A1
(en)
|
2018-03-13 |
2019-09-19 |
Affibody Ab |
Polypeptides based on a novel scaffold
|
|
EP3788343B1
(en)
|
2018-04-30 |
2024-03-27 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
US11649275B2
(en)
|
2018-08-02 |
2023-05-16 |
Duke University |
Dual agonist fusion proteins
|
|
WO2020051541A1
(en)
*
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
CN121971599A
(zh)
|
2019-02-25 |
2026-05-05 |
芝加哥大学 |
用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
|
|
CA3138805A1
(en)
|
2019-06-04 |
2020-12-10 |
Johannes Schilling |
Designed ankyrin repeat domain with improved stability
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
EP3785726A1
(en)
|
2019-09-02 |
2021-03-03 |
Biotest AG |
Factor viii protein with increased half-life
|
|
EP4017521A1
(en)
|
2019-09-02 |
2022-06-29 |
Biotest AG |
Factor viii protein with increased half-life
|
|
US20220389066A1
(en)
|
2019-11-05 |
2022-12-08 |
Affibody Ab |
Polypeptides
|
|
EP4106798A1
(en)
|
2020-02-17 |
2022-12-28 |
Biotest AG |
Subcutaneous administration of factor viii
|
|
EP3878515A1
(en)
*
|
2020-03-09 |
2021-09-15 |
Hober Biotech AB |
Therapeutic agent targeting her2
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
EP4263589A1
(en)
|
2020-12-21 |
2023-10-25 |
Affibody AB |
New polypeptide
|
|
US20240124533A1
(en)
|
2021-02-15 |
2024-04-18 |
Affibody Ab |
New her2-binding polypeptide
|
|
MX2024009732A
(es)
|
2022-02-08 |
2024-08-19 |
Affibody Ab |
Variantes de la proteina z que enlazan la linfopoyetina estromal timica y su uso medico.
|
|
WO2023225534A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|
|
TW202416938A
(zh)
|
2022-08-10 |
2024-05-01 |
日商興和股份有限公司 |
親和體微胞(affibody micelle)藥物複合體
|
|
AR131869A1
(es)
|
2023-02-17 |
2025-05-07 |
Ablynx Nv |
POLIPÉPTIDOS QUE SE UNEN AL RECEPTOR DE Fc NEONATAL
|
|
KR20260007574A
(ko)
|
2023-05-04 |
2026-01-14 |
애피바디 에이비 |
신규 폴리펩티드
|
|
WO2025073871A1
(en)
|
2023-10-03 |
2025-04-10 |
Bicycletx Limited |
Bicyclic peptide ligand complexes specific for tfr1
|
|
TW202545983A
(zh)
|
2024-01-25 |
2025-12-01 |
瑞典商艾菲博迪公司 |
新穎多肽
|
|
CN121041473A
(zh)
*
|
2024-05-29 |
2025-12-02 |
烟台蓝纳成生物技术股份有限公司 |
一种双功能性融合蛋白、放射性核素标记物及其应用
|
|
CN118666961B
(zh)
*
|
2024-08-23 |
2024-11-26 |
通化安睿特生物制药股份有限公司 |
人白蛋白特异结合多肽及其应用
|